B3GAT1: A Potential Drug Target for Cancer and Other Diseases

Target Name: B3GAT1-DT

NCBI ID: G283177

B3GAT1-DT

Other Name(s): B3GAT1 divergent transcript

B3GAT1: A Potential Drug Target for Cancer and Other Diseases

B3GAT1-DT, also known as B3GAT1-Divergent Transcript, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. The gene is located on chromosome 16 and encodes a protein known as B3GAT1.

B3GAT1 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been associated with various cellular processes, including cell growth, differentiation, and inflammation. Studies have also suggested that B3GAT1 may be involved in the development and progression of certain diseases, including cancer.

One of the key features of B3GAT1 is its ability to induce apoptosis, which is the process by which cells undergo programmed cell death. This process is regulated by a complex network of genes and environmental factors, and B3GAT1 has been shown to play a role in this process.

In cancer, B3GAT1 has been shown to promote the development and progression of various subtypes, including epithelial, stem-cell, and neuroendocrine tumors. This is thought to happen by regulating the expression of genes that are critical for cancer cell survival and growth.

In addition to its role in cancer, B3GAT1 has also been associated with a number of other diseases and conditions, including neurodegenerative disorders, autoimmune diseases, and developmental disabilities.

Despite these promising findings, much more research is needed to fully understand the role of B3GAT1 in disease. One of the key challenges in studying this gene is its expression level, as it is difficult to detect in many tissues. Additionally, the functions of B3GAT1 in different cell types and conditions are not well understood, and more research is needed to determine its potential as a drug target or biomarker.

In conclusion, B3GAT1-DT is a gene that has shown promise as a drug target or biomarker for a variety of diseases, including cancer. Further research is needed to fully understand its functions and potential as a therapeutic agent.

Protein Name: B3GAT1 Divergent Transcript

The "B3GAT1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about B3GAT1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets